Abstract
Atrial natriuretic peptide (ANP) stimulates vasodilation, fluid egress, increased glomerular filtration and salt and water excretion, and blocks the release and/or actions of several hormones, including angiotensin II, aldosterone and vasopressin. ANP levels are commonly elevated in situations of excessive fluid volume or hypertension, and the hormone may be important in combatting these states. ANP is derived from a precursor protein produced by the cardiac atrium and at lower levels by other tissues. Two classes of ANP receptors present in vascular, renal and other tissues are linked respectively, to either guanylate cyclase and possibly other second messengers, or to ANP clearance. ANP shows promise as an agent to treat heart failure, renal failure and fluid excess states.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Metzler, C.H., Gardner, D.G., Keil, L.C., Baxter, J.D. and Ramsay, D.J. 1987. Increased synthesis and release of atrial peptide during mineralocorticoid escape in conscious dogs. Am J. Physiol. 252:R188–R192.
Zimmerman, R.S., Edwards, B.S., Schwab, T.R., Heublein, D.M. and Burnett, J.C., Jr. 1987. Atrial natriuretic peptide during mineralocorticoid escape in the human. J. Clin. Endocrin. Metab. 64:624–627.
Knox, F.G., Burnett, J.C., Kohan, D.E., Spielman, W.S., Strand, J.C. 1980. Escape from the sodium retaining effects of mineralocorticoid. Kid. Int. 17:263–276.
Baxter, J.D., Perloff, D., Hsueh, W., Biglieri, E.G. 1987. The endocrinology of hypertension, p. 693–788. In: Endocrinology and Metabolism. P. Felig, J. D. Baxter, A. E. Broadus, L. A. Frohman (Eds.). McGraw Hill, New York.
Haddy, F.J. 1987. Endogenous digitalis-like factor or factors. N. Eng. J. Med. 316:621–623.
Kisch, B. 1956. Electron microscopy of the atrium of the heart. I. Guinea pig. Exp. Med. Surg. 14:99–112.
deBold, A.J. 1979. Heart atrial granularity. Effects of changes in water and electrolyte balance. Proc. Soc. Exp. Biol. Med. 161:508–511.
Marie, J.-P., Guillemot, H. and Hatt, P.Y. 1976. Le degré de granulation des cardiocytes auriculaires: Étude planimetrique au cours de differents apports de'eau et de sodium chez le rat. Pathol. Biol. 24:549–554.
deBold, A.J. 1982. Tissue fractionation studies on the relationship between an atrial natriuretic factor and specific atrial granules. Can. J. Physiol. Pharmacol. 60:324–330.
Atlas, S.A., Kleinert, H.D., Camargo, M.J., Januszewicz, A., Sealey, J.E., Laragh, J.H., Schilling, J.W., Lewicki, J.A., Johnson, L.K. and Maack, T. 1984. Purification, sequencing and synthesis of natriuretic and vasoactive rat atrial peptide. Nature 309:717–719.
Seidah, N.G., Lazure, C., Chretien, M., Thibault, G., Garcia, R., Cantin, M., Genest, J., Nutt, R.F., Brady, S.F., Lyle, T.A., Palereda, W.S., Colton, C.D., Ciccarone, T.M. and Veber, D.F. 1984. Amino acid sequence of homologous rat atrial peptides: Natriuretic activity of native and synthetic forms. Proc. Natl. Acad. Sci. USA 81:2640–2644.
Currie, M.G., Geller, D.M., Cole, B.R., Siegel, N.R., Fok, K.F., Adams, S.P., Eubanks, S.R., Galluppi, G.R. and Needleman, P. 1983. Purification and sequence analysis of bioactive atrial peptides (atriopeptins). Science 21:67–69.
Maki, M., Takayanagi, R., Misono, K.S., Pandey, K.N., Tibbetts, C. and Inagami, T. 1984. Structure of rat ANF precursor deduced from cDNA sequence. Nature 309:722–724.
Seidman, C., Duby, A., Choi, E., Graham, R., Haber, E., Homcy, C., Smith, J. and Seidman, J. 1984. Structure of rat pre-proatrial natriuretic factor as defined by a complementary DNA clone. Science 225:324–326.
Yamanaka, M., Greenberg, B., Johnson, L., Seilhamer, J., Brewer, M., Friedemann, T., Miller, J., Atlas, S., Laragh, J., Lewicki, J. and Fiddes, J. 1984. Cloning and sequence analysis of the cDNA for the rat ANF precursor. Nature 309:719–722.
Zivin, R., Condra, J., Dixon, R., Seidah, N., Chretien, M., Nemer, M., Chamberland, M. and Drouin, J. 1984. Molecular cloning and characterization of DNA sequences encoding rat and human ANF. Proc. Natl. Acad. Sci. USA 81:6325–6329.
Nakayma, K., Ohkubo, H., Hirose, T., Inayama, S. and Nakanishi, S. 1984. mRNA sequence for human cardiodilatin-atrial natriuretic factor precursor and regulation of precursor mRNA in rat atria. Nature 310:699–701.
Oikawa, S., Imai, M., Ueno, A., Tanaka, S., Noguchi, T., Nakazato, H., Kangawa, K., Fukuda, A. and Matsuo, H. 1984. Cloning and sequence analysis of cDNA encoding a precursor for human ANP. Nature 309:724–726.
Oikawa, S., Imai, M., Inuzuka, C., Tawaragi, Y., Nakazato, H. and Matsuo, H. 1985. Structure of dog and rabbit precursors of atrial natriuretic polypeptides deduced from nucleotide sequence of cloned cDNA. Biochem. Biophys. Res. Commun. 132:892–899.
Nakao, K., Itoh, H., Mukoyama, M., Morii, N., Sugawara, A., Yamada, T., Shiono, S., Saito, Y., Arai, H. and Imura, H. 1987. N-Terminal fragment of γ-human atrial natriuretic polypeptide (γ)-human ANP) is present in atrium and co-secreted with α-human ANP into circulation in man. Proceedings of the 2nd World Congress on Biol. Active Peptides. Abst. B9, p. 202.
Forssman, W.G., Hock, D., Lottspeich, F., Henscher, A., Kreyl, V., Christmann, M., Reinecke, M., Metz, J., Carliquist, M. and Mutt, V. 1983. The right auricle of the heart is an endocrine organ. Anat. Embryol. 168:307–313.
Greenberg, B., Bencen, G., Seilhamer, J., Lewicki, J. and Fiddes, J. 1984. Nucleotide sequence of the gene encoding human ANF precursor. Nature 312:656–658.
Maki, M., Parmentier, M., and Inagami, T. 1984. Cloning of the genomic DNA for human ANF. Biochem. Biophys. Res. Commun. 125:797–802.
Seidman, C., Bloch, K., Klein, K., Smith, J., and Seidman, J. 1984. Nucleotide sequences of the human and mouse atrial natriuretic factor genes. Science 226:1206–1209.
Argentin, S., Nemer, M., Drouin, J., Scott, G., Kennedy, B., and Davies, P. 1985. The gene for rat atrial natriuretic factor. J. Biol. Chem. 260:4568–4571.
Vlasuk, G., Miller, J., Bencen, G., and Lewicki, J. 1986. Structure and analysis of the bovine atrial natriuretic peptide precursor gene. Biochem. Biophys. Res. Commun. 136:396–403.
Karin, M., Haslinger, A., Holtgreve, H., Richards, R.I., Krauter, P., Westphal, W.M., and Beato, M. 1984. Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein II gene. Nature 308:513–519.
Nordeim, A., and Rich, A. 1983. Negatively supercoiled simian virus 40 DNA contains Z-DNA segments within transcriptional enhancer sequences. Nature 303:674–679.
Gardner, D.G., Deschepper, C.F., Ganong, W.F., Hane, S., Fiddes, J., Baxter, J.D., and Lewicki, J. 1986. Extra-atrial expression of the gene for atrial natriuretic factor. Proc. Natl. Acad. Sci. USA 83:6698–6701.
Gardner, D.G., Vlasuk, G.P., Baxter, J.D., Fiddes, J.C., and Lewicki, J.A. 1987. Identification of atrial natriuretic factor gene transcripts in the central nervous system of the rat. Proc. Natl. Acad. Sci. USA 84:2175–2179.
Day, M.L., Schwartz, D., Wiegand, R.C., Stockman, P.T., Brunnert, S.R., Tolunay, H.E., Currie, M.G., Standaert, D.G., and Needle-man, P. 1987. Ventricular atriopeptin: unmasking of mRNA and peptide synthesis by hypertrophy or dexamethasone. Hypertension 9:485–491.
Lattion, A.-L., Michel, J.-B., Arnauld, E., Corvol, P., and Sombrier, F. 1986. Myocardial recruitment during ANF mRNA increase with volume overload in the rat. Am. J. Physiol. 251:H890–H896.
Bloch, K.D., Seidman, J.G., Naftilan, J.D., Fallon, J.T., and Seidman, C.E. 1986. Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathways. Cell 47:695–702.
Gardner, D.G., Deschepper, C.F., and Baxter, J.D. 1987. The gene for the atrial natriuretic factor is expressed in the aortic arch. Hypertension 9:103–106.
Saper, C.B., Standaert, D.G., Currie, M.G., Schwartz, D., Geller, D.M., and Needleman, P. 1985. Atriopeptin-immunoreactive neurons in the brain: Presence in cardiovascular regulatory areas. Science 227:1047–1049.
Jacobowitz, D.M., Skofitsch, G., Keiser, H.R., Eskay, R.L., and Zamir, N. 1985. Evidence for the existence of atrial natriuretic factor-containing neurons in the rat brain. Neuroendocrinology 40 92–94.
Glembotski, C.C., Wildey, G.M., and Gibson, T.R. 1985. Molecular forms of immunoreactive atrial natriuretic peptide in the rat hypothalamus and atrium. Biochem. Biophys. Res. Commun. 129:671–678.
Shiono, S., Nakao, K., Morii, N., Yamada, T., Itoh, H., Sakamoto, M., Sugawara, A., Saito, Y., Katsuura, G., and Imura, H. 1986. Nature of atrial natriuretic polypeptide in rat brain. Biochem. Biophys. Res. Commun. 135:728–736.
Standaert, D.G., Needleman, P., and Saper, C.B. 1986. Organization of atriopeptin-like immunoreactive neurons in the central nervous system of the rat. J. Comp. Neuro. 253:315–341.
Debinski, W., Gutkowska, J., Kuchel, O., Racz, K., Buu, N.T., Cantin, M., and Genest, J. 1987. Presence of an atrial natriuretic factor-like peptide in the rat superior cervical ganglion. Neuroendocrinology 46:236–240.
Debinski, W., Gutkowska, J., Kuchel, O., Racz, K., Buu, N.T., Cantin, M., and Genest, J. 1986. ANF-like peptides in the peripheral autonomic nervous system. Biochem. Biophys. Res. Commun. 134:279–284.
McKenzie, J.C., Tanaka, I., Misono, K.S., and Inagami, T. 1985. Immunocytochemical localization of atrial natriuretic factor in the kidney, adrenal medulla, pituitary and atrium of the rat. J. of Histochem. and Cytochem. 33:828–832.
Schwartz, D., Geller, D.M., Manning, P.T., Siegel, N.R., Fok, F., Smith, C.E., and Needleman, P. 1985. Ser-Leu-Arg-Arg-Atriopeptin III: The major circulating form of atrial peptide. Science 229:397–400.
Vuolteenaho, O., Arjamaa, O., and Ling, N. 1985. Atrial natriuretic polypeptides (ANP): rat atria store high molecular weight precursor but secrete processed peptides of 25–35 amino acids. Biochem. Biophys. Res. Commun. 129:82–88.
Bloch, K.D., Scott, J.A., Zisfein, J.B., Fallon, J.T., Margolis, M.N., Seidman, C.E., Matsueda, G.R., Homcy, C.J., Graham, R.M., and Seidman, J.G. 1985. Biosynthesis and secretion of proatrial natriuretic factor by cultured rat cardiocytes. Science 230:1168–1171.
Hilliker, S., Vlasuk, G., Borden, L., Hancock, N., Scarborough, R., Schwartz, L., and Lewicki, J. 1986. Fate of the atrial natriuretic peptide precursor in the circulation. Program of the 1st World Conference on Biol. Active Peptides. Abst. p. 90A.
Trippodo, N.C., Januszewicz, A., Pegram, B.L., Cole, F.E., Kohashi, N., Kardon, M.B., MacPhee, A.A., and Frohlich, E.D. 1985. Rat platelets activate high molecular weight atrial natriuretic peptides in vitro. Hypertension 7:905–912.
Bloch, K.D., Zisfein, J.B., Margolies, M.N., Homcy, C.J., Seidman, J.G., and Graham, R.M. 1987. A serum protease cleaves pro-ANF into a 14-kiloDalton peptide and ANF. Am. J. Physiol. 252:E147–E151.
Gibson, T.R., Shields, P.P., and Glembotski, C.C. 1987. The conversion of atrial natriuretic peptide (ANP)- (1–126) to ANP- (99–126) by rat serum: contribution to ANP cleavage in isolated perfused rat hearts. Endocrinology 120:764–772.
Imada, T., Takayanagi, R., and Inagami, T. 1987. Identification of a peptidase which processes atrial natriuretic factor precursor to its active form with 28 amino acid residues in particulate fraction of rat atrial homogenate. Biochem. Biophys. Res. Commun. 143:587–592.
Rittenhouse, J., Moberly, L., O'Donnell, M.E., Owen, N.E., and Marcus, F. 1986. Phosphorylation of atrial natriuretic peptides by cyclic AMP-dependent protein kinase. J. Biol. Chem. 261:7607–7610.
Bloch, K.D., Jones, S.W., Preibisch, G., Seipke, G., Seidman, C.E., and Seidman, J.G. 1987. Proatrial natriuretic factor is phosphorylated by rat cardiocytes in culture. J. Biol. Chem. 262:9956–9961.
Lang, R.E., Tholken, H., Ganten, D., Luft, F.C., Ruskoaho, H., and Unger, Th. 1985. Atrial natriuretic factor-a circulating hormone stimulated by volume loading. Nature 314:264–266.
Ballerman, B.J., Bloch, K.D., Seidman, J.G., and Brenner, B.M. 1986. Atrial natriuretic peptide transcription, secretion and giomerular receptor activity during mineralocorticoid escape in the rat. J. Clin. Invest. 78:840–843.
Garcia, R., Debinski, W., Gutkowska, J., Kuchel, O., Thibault, G., Genest, J., and Cantin, M. 1985. Gluco- and mineralocorticoids may regulate the natriuretic effect and the synthesis and release of atrial natriuretic factor by the rat atria in vivo. Biochem. Biophys. Res. Commun. 131:806–814.
Ding, J., Thibault, G., Gutkowska, J., Garcia, R., Karabatsos, T., Gaetan, J., Genest, J., and Cantin, M. 1987. Cardiac and plasma atrial natriuretic factor in experimental congestive heart failure. Endocrinology 12:248–257.
Cody, R.J., Atlas, S.A., Laragh, J.H., Kubo, S.H., Covit, A.B., Ryman, K.S., Shakanovich, A., Pondolfino, K., Clark, M., Camargo, M.J.F., Scarborough, R.M., and Lewicki, J.A. 1986. Atrial natriuretic factor in normal subjects and heart failure patients. J. Clin. Invest. 78:1362–1374.
Imada, T., Takayanagi, R., and Inagami, T. 1985. Changes in the content of atrial natriuretic factor with the progression of hypertension in spontaneously hypertensive rats. Biochem. Biophys. Res. Commun. 133:759–765.
Snajdar, R.M., and Rapp, J.P. 1986. Elevated atrial natriuretic polypeptide in plasma of hypertensive Dahl salt-sensitive rats. Biochem. Biophys. Res. Commun. 137:876–883.
Manning, P.T., Schwartz, D., Katsube, N.C., Holmberg, S.W., and Needleman, P. 1985. Vasopressin-stimulated release of atriopeptin: Endocrine antagonists in fluid homeostasis. Science 229:395–397.
Metzler, C.H., Lee, M.-E., Thrasher, T.N., and Ramsay, D.J. 1986. Increased right or left atrial pressure stimulates release of atrial natriuretic peptides in conscious dogs. Endocrinology 119:2396–2398.
Gardner, D.G., Hane, S., Trachewsky, D., Schenk, D., and Baxter, J.D. 1986. Atrial natriuretic peptide mRNA is regulated by glucocorticoids in vivo. Biochem. Biophys. Res. Commun. 139:1047–1054.
Gardner, D.G., Gertz, B.J., and Hane, S. 1987. Thyroid hormone increases ANP mRNA accumulation in vivo, and in vitro. Molec. Endocrinology 1:260–265.
Kohno, M., Takaori, K., Matsuura, T., Murakewa, K., Kanayama, Y., and Takeda, T. 1986. Atrial natriuretic polypeptide in atria and plasma in experimental hyperthyroidism and hypothyroidism. Biochem. Biophys. Res. Commun. 134:178–183.
Dietz, J.R. 1984. Release of atrial natriuretic factor from rat heart-lung preparation by atrial distension. Am. J. Physiol. 247:R1093–R1096.
Schiebinger, R.J., Baker, M.Z., and Linden, J. 1987. Effect of adrenergic and muscarinic cholinergic agonists on atrial natriuretic peptide secretion by isolated rat atria. J. Clin. Invest. 80:1687–1691.
Schiebinger, R.J. and Linden, J. 1986. The influence of resting tension on immunoreactive atrial natriuretic peptide secretion by rat atria superfused in vitro. Circ. Res. 59:105–109.
Schiebinger, R.J. and Linden, J. 1986. Effect of atrial contraction frequency on atrial natriuretic peptide secretion. Am. J. Physiol. 251:H1095–H1099.
Ruskoaho, H., Toth, M., and Lang, R.E. 1985. Atrial natriuretic peptide secretion: Synergistic effect of phorbol ester and A23187. Biochem. Biophys. Res. Commun. 133:581–588.
Sonnenberg, H. and Veress, A.T. 1984. Cellular mechanism of release of atrial natriuretic factor. Biochem. Biophys. Res. Commun. 124:443–449.
Takayanagi, R., Taneka, I., Maki, M., and Inagami, I. 1985. Effects of changes in water-sodium balance on levels of atrial natriuretic factor messenger RNA and peptide in rats. Life Sci. 36:1843–1848.
Gardner, D.G., LaPointe, M.C., Wu, J., Baxter, J.D., and Gertz, B.J. 1988. Hormonal regulation of the gene for atrial natriuretic factor in press. In: Advances in Atrial Peptide Research, Vol. II. John H. Laragh and Barry M. Brenner (Eds.). Raven Press: New York.
Grekin, R.J., Ling, W.D., Shenker, Y., and Bohr, D.F. 1986. Immunoreactive atrial natriuretic hormone levels increase in deoxy-corticosterone acetate-treated pigs. Hypertension 8:II16–II20.
Needleman, P. and Greenwald, J.E. 1986. Atriopeptin: A cardiac hormone intimately involved in fluid, electrolyte and blood-pressure homeostasis. N. Engl. J. Med. 314:828–834.
deBold, A.J. 1985. Atrial natriuretic factor: A hormone produced by the heart. Science 230:767–769.
Maack, T., Suzuki, M., Almeida, F.A., Nussenzveig, D., Scarborough, R.M., McEnroe, G.A., and Lewicki, J.A. 1987. Physiological role of silent receptors of atrial natriuretic factor. Science 238:675–678.
Ballermann, B.J. and Brenner, B.M. 1985. Biologically active atrial peptides. J. Clin. Invest. 76:2041–2048.
Yamaji, T., Ishibashi, M., and Takaku, F. 1985. Atrial natriuretic factor in human blood. J. Clin. Invest. 76:1705–1709.
Burnett, J.C., Jr., Kao, P.C., Hu, D.C., Heser, D.W., Heublein, D., Granger, J.P., Opgenorth, T.J., and Reeder, G.S. 1986. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 231:1145–1147.
Atlas, S.A. 1986. Atrial natriuretic factor: A new hormone of cardiac origin. Rec. Prog. Hormone Res. 42:207–242.
Rascher, W., Tulassay, T., and Lang, R.E. 1985. Atrial natriuretic peptide in plasma of volume-overloaded children with chronic renal failure. Lancet 2:303–305.
Weidmann, P., Hasler, L., Gnadinger, M.P., Lang, R.E., Uehlinger, D.E., Shaw, S., Rascher, W., and Reubi, F.C. 1986. Blood levels and renal effects of atrial natriuretic peptide in normal man. J. Clin. Invest. 77:734–742.
Adams, S.P. 1987. Structure and biologic properties of the atrial natriuretic peptides, p. 1–17. In: Endocrinology and Metabolism Clinics of North America: Atrial Natriuretic Factor. M. Rosenblatt and J. W. Jacobs (Eds). W. B. Saunders Co.
Atlas, S.A. and Maack, T. 1987. Effects of atrial natriuretic factor on the kidney and the rennin-angiotensin-aldosterone system, p. 107–143. Ibid.
Leitman, D.C. and Murad, F. 1987. Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation, p. 79–105. Ibid.
Winquist, R.J. 1987. Pharmacologic effects of atrial natriuretic peptide, p. 163–182. Ibid.
Cogan, M.G. 1986. Atrial natriuretic factor can increase renal solute excretion primarily by raising glomerular filtration. Am. J. Physiol. 250:F710–F714.
Huang, C.L., Lewicki, J., Johnson, L.K., and Cogan, M.G. 1985. Renal mechanism of action of rat atrial natriuretic factor. J. Clin. Invest. 75:769–773.
Samson, W.K. 1985. Atrial natriuretic factor inhibits dehydration-and hemorrhage-induced vasopressin release. Neuroendocrinology 20:227–279.
Zeidel, M.L., Seifter, J.L., Lear, S., Brenner, B.M., and Silva, P. 1986. Atrial peptides inhibit oxygen consumption in kidney medullary collecting duct cells. Am. J. Physiol. 251:F379–F383.
Cuneo, R.C., Espiner, E.A., Nicholls, M.G., Yandle, T.G., and Livesey, J.H. 1987. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man. J. Clin. Endocrin. Metab. 65:765–772.
Tikkanen, I., Metsarinne, K., Fyhrquist, F., Leidenius, R. 1985. Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers. Lancet ii:66–69.
Biollaz, J., Nussberger, J., Porchet, M., Brunner-Feber, F., Otterbein, E.S., Gomez, H., Waeber, B., and Brunner, H.R. 1986. Four-hour infusions of synthetic atrial natriuretic peptide in normal volunteers. Hypertension 8:II96–II105.
Saito, Y., Nakao, K., Nishimura, K., Sugawara, A., Okumura, K., Obata, K., Sonoda, R., Ban, T., Yasue, H., and Imura, H. 1987. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation 76:115–124.
Xu, C., Jiang, B., Wang, J., Sun, N., Chen, H., Liu, X., Tian, Y., Chen, S., Li, D., Xie, C., and Tang, J. 1986. Hemodynamic and renal effects of human alpha atrial natriuretic peptide in two patients with congestive heart failure. Chinese Med. J. 99:1.
Huxley, V.H., Tucker, V.L., Verburg, K.M., and Freeman, R.H. 1986. Increased capillary hydraulic conductivity induced by atrial natriuretic peptide. Circ. Res. 60:304–307.
Samson, W.K. 1987. Atrial natriuretic factor and the central nervous system, p. 145–161. In: Endocrinology and Metabolism Clinics of North America: Atrial Natriuretic Factor. Op. cit.
Nicholls, M.G. and Richards, A.M. Human studies with atrial natriuretic factor, p. 199–223. Ibid.
Debinski, W., Kuchel, O., Buu, N.T., Cantin, M., and Genest, J. 1987. Atrial natriuretic factor partially inhibits the stimulated catecholamine synthesis in superior cervical ganglia of the rat. Neuroscience Letters 17:92–99.
Standaert, D.G., Cechette, D.F., Needleman, P., and Saper, C.B. 1987. Inhibition of the firing of vasopressin neurons by atriopeptin. Nature 329:151–153.
Antunes-Rodriguez, J., McCann, S.M., and Samson, W.K. 1986. Central administration of atrial natriuretic factor inhibits saline preference in the rat. Endocrinology 118:1726–1728.
Antunes-Rodriguez, J., McCann, S.M., Rogers, L.C., and Samson, W.K. 1985. Atrial natriuretic factor inhibits dehydration and angiotensin II induced water intake in the conscious unrestrained rat. Proc. Natl. Acad. Sci. USA 82:8720–8723.
DeLean, A., Gutowska, J., McNicoll, N., Schiller, P.W., Cantin, M., Genest, J. 1984. Characteristics of specific receptors for atrial natriuretic factor in bovine adrenal zona glomerulosa. Life Sci. 35:2311–2318.
Inui, K., Saito, H., Matsukawa, Y., Nakao, K., Morii, N., Imura, H., Shimokura, M., Kiso, Y., and Hori, R. 1985. Specific binding activities and cyclic GMP responses by atrial natriuretic polypeptide in kidney epithelial cell line (LLC-PK1). Biochem. Biophys. Res. Commun. 132:253–260.
Napier, M.S., Vandlen, R.L., Albers-Schonberg, G., Mutt, R.F., Brady, S., Lyle, T., Winquist, R., Faison, E.P., Heinel, L.A., and Blaine, E. II. 1984. Specific receptors for atrial natriuretic factor in renal and vascular tissues. Proc. Natl. Acad. Sci. USA 81:5946–5950.
Shenk, D.B., Johnson, K.K., Schwartz, K., Sista, H., Scarborough, R.M., and Lewicki, J.A. 1985. Distinct atrial natriuretic factor receptor sites on cultured bovine aortic smooth muscle and endothelial cells. Biochem. Biophys. Res. Commun. 127:433–442.
Bianchi, C., Gutkowska, J., Thibault, G., Garcia, R., Genest, J., and Cantin, M. 1985. Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat adrenal and kidney. Histochemistry 82:441–452.
Scarborough, R.M., Schenk, D.B., McEnroe, G.A., Arfsten, A., Kang, L.-L., Schwartz, K., and Lewicki, J.A. 1986. Truncated atrial natriuretic peptide (ANP) analogs: Comparison between receptor binding affinity and cyclic GMP stimulation in cultured aortic smooth muscle cells. J. Biol. Chem. 261:12960–12964.
Leitman, D.C. and Murad, F. 1986. Comparison of binding and cyclic GMP accumulation by atrial natriuretic peptides in endothelial cells. Biochim. Biophys. Acta. 885 74–79.
Takayanagi, R., Snajdar, R.M., Imada, T., Tamura, M., Pandey, K.N., Misono, K.S., and Inagami, T. 1987. Purification and characterization of two types of atrial natriuretic factor receptors from bovine adrenal cortex: Guanylate cyclase-linked and cyclase-free receptors. Biochem. Biophys. Res. Commun. 144:244–250.
Waldman, S.A., Rapoport, R.M., and Murad, F. 1986. Cyclic Guanosine Monophosphate as a mediator of vasodilation. J. Clin. Invest. 78:1–5.
Scarborough, R., McEnroe, G., Kang, L.L., Arfsten, A., Schwartz, Almeida, F., Maack, T., and Lewicki, J. 1987. Receptor interactions of atrial natriuretic peptide ring deletion analogs. Second World Congress on Biologically Active Atrial Peptides. New York. Abst. B173.
Ashwell, G., Harford, J. 1982. Carbohydrate-specific receptors of the liver. Ann. Rev. Biochem. 51:531–554.
Yamamoto, T., Davis, C.G., Brown, M.S., Schneider, W.J., Casey, M.L., Goldstein, J.L., and Russell, D.W. 1984. The human LDL receptor: A cysteine-rich protein with multiple alu sequences in its mRNA. Cell 39:27–38.
McClelland, A., Kuhn, L.C., and Ruddle, F.H. 1984. The human transferrin receptor gene: Genomic organization, and the complete primary structure of the receptor deduced from a cDNA sequence. Cell 39:267–274.
Oka, Y., and Czech, M.P. 1986. The type II insulin-like growth factor receptor is internalized and recycles in the absence of ligand. J. Biol. Chem. 261:9090–9093.
Kuno, T., Andersen, J.W., Kamisaki, Y., Waldman, S.A., Chang, L.Y., Saheki, S., Leitman, D.C., Nakane, M., and Murad, F. 1986. Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung. J. Biol. Chem. 261:5817–5823.
Takayanagi, R., Inagami, T., Snajdar, R.M., Imada, T., Tamura, M., and Misono, K.S. 1987. Two distinctive forms of receptors for atrial natriuretic factors in bovine adrenocortical cells. J. Biol. Chem. 262:12104–12113.
Shenk, D.B., Phelps, M.N., Porter, J.G., Fuller, F., Cordell, B., and Lewicki, J.A. 1987. Atrial natriuretic peptide receptor: Purification and elucidation of its structural subunit composition. Proc. Natl. Acad. Sci. USA 84:1521–1524.
Hirose, S., Akiyama, F., Shinjo, M., Ohno, H., and Murakami, K. 1985. Solubilization and molecular weight estimation of atrial natriuretic factor receptor from bovine adrenal cortex. Biochem. Biophys. Res. Commun. 130:574–579.
Vandien, K.L., Arcuri, K.E., and Napier, M.A. 1985. Identification of a receptor for atrial natriuretic factor in rabbit aorta membranes by affinity crosslinking. J. Biol. Chem. 260:10889–10922.
Shenk, D.B., Phelps, M., Porter, J.G., Scarborough, R.M., McEnroe, G.A., and Lewicki, J. 1985. Identification of the receptor for atrial natriuretic factor in cultured vascular cells. J. Biol. Chem. 260:14887–14890.
Fuller, F., Porter, J.G., Arfsten, A., Miller, J., Schilling, J., Scarborough, R.M., Lewicki, J., and Schenk, D.B. 1988. Atrial natriuretic peptide C-receptor: Complete sequence and functional expression of cDNA clones. J. Biol. Chem., in press.
Schenk, D., Porter, G., Fuller, F., Arfsten, A., Lewicki, J. 1987. Cloning and expression of the receptor for atrial natriuretic factor. Program of the 2nd World Congress on Biologically Active Atrial Peptides. p. 190.
Raine, A.E.G., Erne, P., Burgisser, E., Muller, F.B., Bolli, P., Burkart, F., and Buhler, F.R. 1986. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N. Engl. J. Med. 315:533–537.
Crozuer, I.G., Nicholls, M.G., Ikram, H., Espiner, E.A., Gomez, H.J., and Warner, N.J. 1986. Haemodynamic effects of atrial peptide infusion in heart failure. Lancet (ii):1242–1245.
Edwards, B.S., Zimmerman, R.S., and Burnett, J.D., Jr. 1987. Atrial natriuretic factor: Physiologic actions and implications in congestive heart failure. Card. Drugs & Therapy 1:89–99.
Schiffrin, E.L. 1986. Down-regulations of binding sites for atrial natriuretic peptide in platelets of patients with congestive heart failure. Circulation 72:II–463.
Burnett, J.C., Jr. 1987. Atrial natriuretic factor secretion: Physiological regulation and implications in cardiovascular disease. Current Opinion in Cardiology 2:653–659.
Nicklas, J.M., DiCarlo, L.A., Koller, P.T., Morady, F., Diltz, E.A., Shenker, Y., and Grekin, R.J. 1986. Plasma levels of immunoreactive atrial natriuretic factor increase during supraventricular tachycardia. Am. Heart J. 112:923–927.
Achiebinger, R.J. and Linden, J. 1986. Effect of atrial contraction frequency on atrial natriuretic peptide secretion. Am. J. Physiol. 251:H1095–H1099.
Sagnella, G.A., Markandu, N.D., Shore, A., and MacGregor, G.A. 1986. Raiser circulating levels of atrial natriuretic peptides in essential hypertension. Lancet ii:179–181.
Sugawara, A., Nakao, K., Sakamoto, M., Morii, N., Yamada, T., Itoh, H., Shiono, S., and Imura, H. 1985. Plasma concentrations of atrial natriuretic polypeptide in essential hypertension. Lancet ii:1426–1427.
Edwards, B.S., Schwab, T.R., Zimmerman, R.S., Heublein, D.M., Jiang, N.-S., and Burnett, J.C., Jr. 1986. Cardiovascular, renal and endocrine response to atrial natriuretic peptide in angiotensin II mediated hypertension. Circ. Res. 59:663–667.
Zachariah, P.K., Burnett, J.C., Jr., Ritter, S., and Strong, C.G. 1986. Atrial natriuretic peptide in essential hypertension. Clin. Res. 34:489A.
Tanaka, I., and Inagami, T. 1986. Increased concentration of plasma immunoreactive atrial natriuretic factor in Dahl salt sensitive rats with sodium chloride-induced hypertension. J. Hypertension 4:109–112.
Petterson, A., Ricksten, S.E., Towle, A., Hedner, J., and Hedner, T. 1985. Plasma atrial natriuretic peptide and hemodynamics in conscious normotensive and spontaneously hypertensive rats after acute blood volume expansion. J. Hypertension 3:S311–S313.
Ackermann, D.M., Edwards, B.S., Wold, L.E., and Burnett, J.C., Jr. 1986. Atrial natriuretic peptide: Localization in the human heart. J. Amer. Med. Assoc. 256:1048.
Shionoiri, H. and Kaneko, Y. 1986. Intranasal administration of alpha-human natriuretic peptide produces a prolonged diuresis in healthy man. Life Sci. 38:773–778.
Su, K.S.E. 1986. Intranasal delivery of peptides and proteins. Pharmacy International 7:8–11.
DeSchurder, I., Sandaert, A., Germonpre, P., DeBuyzere, M., Delangle, J., and Clement, D. 1987. Hemodynamic effects of atrial natriuretic hormone in congestive heart failure. Cardiovascular Drugs and Therapy 1:226.
Rose, G., Freitag, J., Ling, G., Marder, H., Walker, B. 1987. Effects of anaritide (hANP 102–126) infusions in patients with congestive heart failure. Cardiovascular Drugs and Therapy 1:283.
Gomez, H.J., Smith, R., Warner, M., Mulcaky, W., Nicolodi, L., Smith, S., Irvin, J. 1987. Pharmacological effect and tolerability of atrial natriuretic peptide in man. Cardiovascular Drugs and Therapy 1:242.
Packer, M., Kessler, P.D., and Gottlieb, S.S. 1986. Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: Pathophysiology and management. Postgrad. Med. J. 62:179–182.
Gunnells, J.C. 1982. Treatment of Systemic Hypertension, p. 1203–1204. In: The Heart. J. W. Hurst (Ed). McGraw Hill, New York.
Brabant, G., Juppner, H., Kirschner, M., Boker, K., Schmidt, F.W., and Hesch, R.D. 1986. Human atrial natriuretic peptide (ANP) for the treatment of patients with liver cirrhosis and ascites. Klin. Wochenschr. 64:108–111.
Nakamoto, M., Shapiro, J.I., Stanley, P.F., Chan, L., and Schrier, R.W. 1987. In vitro, and in vivo protective effect of atriopeptin III on ischemic acute renal failure. J. Clin. Invest. 80:698–705.
Shaw, S., Weidmann, P., Hodler, J., Zimmerman, A., and Puternastro, A. 1987. Atrial natriuretic peptide protects against acute ischemic renal failure in the rat. J. Clin. Invest. 80:1232–1237.
Cole, B.R., Kuhnline, M.A., and Needleman, P. 1985. Atriopeptin III: A potent natriuretic, diuretic, and hypotensive agent in rats with chronic renal failure. J. Clin. Invest. 76:2413–2415.
Conger, J.D., Falk, S.A., and Schrier, R.W. 1987. Effects of combined atrial natriuretic factor (ANF) and dopamine (D) on acute renal ischemia. Program of the 20th Annual Meeting of the American Society of Nephrology, p. 112A.
Richards, A.M., Nicholls, M.G., Espiner, E.A., Ikram, H., Yandle, T.G., Joyce, S.L., and Cullens, M.M. 1985. Effects of α-human atrial natriuretic peptide in essential hypertension. Hypertension 7:812–817.
Ortola, F.V., Ballermann, B.J., Anderson, S., Mendez, R.E., Brenner, B.M., Adam, E., Lamm, S., Clarey, L.E., Downes, S.J., Riley, S.L., Sandquist, K.J., and Troy, J.L. 1987. Elevated plasma atrial natriuretic peptide levels in diabetic rats: Potential mediator of hyperfiltration. J. Clin. Invest. 80:670–674.
Zatz, R., Meyer, T.W., Remke, H.G., and Brenner, B.M. 1985. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc. Natl. Acad. Sci. USA 82:5963–5967.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baxter, J., Lewicki, J. & Gardner, D. Atrial Natriuretic Peptide. Nat Biotechnol 6, 529–546 (1988). https://doi.org/10.1038/nbt0588-529
Issue Date:
DOI: https://doi.org/10.1038/nbt0588-529